CD80 / CD28LG Molecule
B7-1 / CD80 Molecule Synonym Name
B7-1 / CD80 Protein Products
|Cat No||Species||Product Description|
|B71-H5228||Human||Human B7-1 / CD80 Protein|
|B71-H5259||Human||Human B7-1 / CD80 Protein, Fc Tag (HPLC-verified)|
|B71-H82F2||Human||Biotinylated Human B7-1 / CD80 Protein, Fc Tag, Avi Tag (Avitag?)|
|CD0-C5252||Cynomolgus||Cynomolgus B7-1 / CD80 Protein, Fc Tag|
|CD0-C52H3||Cynomolgus||Cynomolgus B7-1 / CD80 Protein (HPLC-verified)|
|CD0-M5228||Mouse||Mouse B7-1 / CD80 Protein|
|CD0-M5259||Mouse||Mouse B7-1 / CD80 Protein, Fc Tag|
B7-1 / CD80 Molecule Background
B7-1 and B7-2, together with their receptors CD28 and CTLA?4, constitute one of the dominant co-stimulatory pathways that regulate T? and B?cell responses. Although both CTLA?4 and CD28 can bind to the same ligands, CTLA?4 binds to B7?1 and B7?2 with a 20 ? 100 fold higher affinity than CD28 and is involved in the down?regulation of the immune response. B-lymphocyte activation antigen B7-1 (referred to as B7) also known as cluster of Differentiation 80 (CD80), is a member of cell surface immunoglobulin superfamily and is expressed on activated B cells, activated T cells, macrophages and dendritic cells. It is the ligand for two different proteins on the T cell surface: CD28 (for autoregulation and intercellular association) and CTLA-4 (for attenuation of regulation and cellular disassociation). CD80 works in tandem with CD86 to prime T cells. CD80 plays a role in induction of innate immune responses by activating NF-κB-signaling pathway in macrophages. CD80 is thus regarded as promising therapeutic targets for autoimmune diseases and various carcinomas.
- (1) Peach RJ., et al., 1995, J. Biol. Chem. (UNITED STATES) 270 (36): 21181–7.
- (2) Stamper CC., et al., 2001, Nature (England) 410 (6828): 608–11.
- (3) Bhatia S., et al., 2005, Proc. Natl. Acad. Sci. 102: 15569-15574.
- (4) Khan N., et al., 2007, Int. Immunol. 19:477-486.